|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments, available for sale | ||||||||||||||||||||
| Accounts receivable, net of allowances of $23.1 and $22.0 million, respectively | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, net of allowances of $30.9 million and $32.3 million, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Restricted cash equivalents and investments | ||||||||||||||||||||
| Restricted cash equivalents | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued and other liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Convertible senior notes, net – current | ||||||||||||||||||||
| Operating lease liabilities – current | ||||||||||||||||||||
| Income taxes payable – current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Convertible senior notes, net – noncurrent | ||||||||||||||||||||
| Imputed financing obligation related to build-to-suit lease | ||||||||||||||||||||
| Operating lease liabilities – noncurrent | ||||||||||||||||||||
| Contingent and other liabilities – noncurrent | ||||||||||||||||||||
| Noncurrent income taxes payable | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Income taxes payable – noncurrent | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value; 5,000 shares authorized; none issued and outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value; 150,000 shares authorized; 55,898 and 55,347 shares issued, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost; 13,018 and 12,927 shares, respectively | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
